Physician profile
Shelly Esnard
NPI 1750624300
$140,786.26
in general payments reported to CMS, 2019-2025
8 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21K · 2022: $51K · 2023: $32K · 2024: $24K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Travel and Lodging: $4,493 · Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,025.16 |
| Travel and Lodging | $4,493.09 |
| Food and Beverage | $1,747.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $71,288.74 | 2021-2022 | |
| Abbvie INC. | $68,952.17 | 2023-2025 | |
| Galderma Laboratories, L.P. | $175.05 | 2021-2024 | |
| Abbott Laboratories | $144.85 | 2023 | Freestyle Libre |
| Tactile Systems Technology INC | $106.26 | 2022 | |
| Jazz Pharmaceuticals INC. | $57.43 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.96 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.80 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Esnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.